Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannis Tsouderos

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Pharmacology|August 15, 2002
In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiationRoland Baron, Yannis Tsouderos
Medecine Sciences : M/S|October 6, 2004
[Scientific research and therapeutic innovation: an ambition-sharing]Emmanuel Canet, Yannis Tsouderos, Laurent Perret
Lancet (London, England)|June 14, 2011
Mediator: who's to blame?Lucy Vincent, Béatrice Guardiola, Yannis Tsouderos, et al.
Bone|July 21, 2009
Re: "Effect of long-term treatment with strontium ranelate on bone strontium content" by Bärenholdt et al. (Bone, 2009)Patricia Belissa-Chatelain, Isabelle Dupin-Roger, Fabienne Cournarie, et al.
Seminars in Arthritis and Rheumatism|August 9, 2005
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in ScienceEric C Abadie, Jean-Pierre Devogealer, Johann D Ringe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2005
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster, Eric Abadie, Pierre Delmas, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Current Medical Research and Opinion|December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RAJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Seminars in Arthritis and Rheumatism|September 3, 2013
Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Mickaël Hiligsmann, Cyrus Cooper, Nigel Arden, et al.
Drugs & Aging|June 19, 2015
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and FrailtyNigel Arden, Pascal Richette, Cyrus Cooper, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Pharmacology|August 15, 2002
In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiationRoland Baron, Yannis Tsouderos
Medecine Sciences : M/S|October 6, 2004
[Scientific research and therapeutic innovation: an ambition-sharing]Emmanuel Canet, Yannis Tsouderos, Laurent Perret
Lancet (London, England)|June 14, 2011
Mediator: who's to blame?Lucy Vincent, Béatrice Guardiola, Yannis Tsouderos, et al.
Bone|July 21, 2009
Re: "Effect of long-term treatment with strontium ranelate on bone strontium content" by Bärenholdt et al. (Bone, 2009)Patricia Belissa-Chatelain, Isabelle Dupin-Roger, Fabienne Cournarie, et al.
Seminars in Arthritis and Rheumatism|August 9, 2005
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in ScienceEric C Abadie, Jean-Pierre Devogealer, Johann D Ringe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2005
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster, Eric Abadie, Pierre Delmas, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Current Medical Research and Opinion|December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RAJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Seminars in Arthritis and Rheumatism|September 3, 2013
Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Mickaël Hiligsmann, Cyrus Cooper, Nigel Arden, et al.
Drugs & Aging|June 19, 2015
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and FrailtyNigel Arden, Pascal Richette, Cyrus Cooper, et al.
Pageof 2